Introduction
Lymphatic vessel invasion has been shown to be a strong and independent prognostic factor in cases of esophageal squamous cell cancer.
1,2,3) In contrast to the identification of lymphatic cancer invasion using conventional staining, recently developed antibodies such as D2-40 (anti-human podoplanin antibody) have allowed more acurate identification of gastrointestinal mucosal lymphatic vessels including those of the esophagus. 4) In this context, many research groups have focused on individual differences in lymphatic vessel density among patients with esophageal squamous cell carcinoma. 5, 6, 7) These studies have revealed that lymphatic density is s ignificantly correlated with nodal involvement, and thus possibly with prognosis. However, to our knowledge, no previous study has investigated whether certain individual differences in lymphatic vessel morphology are present in the esophagus distant from the cancer, although systemic changes in lymphatics other than those of the esophagus have been suggested in cancer patients. 8, 9) Recently, using donated cadavers without cancer, Yajin et al. 10) demonstrated individual differences of more than 2-fold in the "length or number of the mucosal lymphatics per 1-mm length of the esophageal epithelium". This led them to suggest that, before the onset of cancer pathology, the "pre-existing" mucosal lymphatic vessels exhibit significant individual differences. On the basis of their s tudies, we hypothesized that, even in cancer patients, the morphology of lymphatics distant from the cancer site is likely to reflect any "pre-existing" morphology. How much of a distance from the cancer site is necessary? In the present study, we hypothesized that a distance of 10 cm anal from the pathologically estimated cancer margin would be free Methods: D2-40 immunohistochemistry for human lymphatic epithelium was performed at sites about 10 cm anal from the pathologically examined margin of upper or mid-thoracic squamous cell carcinoma (27 patients). we measured the entire length of mucosal lymphatic vessels within a ×10 objective field (1.2 mm along the muscularis mucosae).
results: the present morphometrical study demonstrated significant individual differences in the amount of mucosal lymphatic vessels, within a range of more than 10-fold (8.4 mm-0.8 mm within an objective field). However, the difference in length of the mucosal lymphatic epithelium did not correlate with either N-factor, t-factor including cancer depth or prognosis.
Conclusion: a higher density of pre-existing mucosal lymphatic vessels may not always be correlated with larger numbers of nodal metastases. Lymphatic proliferation or dilation induced by cancer seems to occur irrespective of whether pre-existing vessels are rich or sparse.
* Correspondence to Shogo Hayashi, MD, PhD, Medical Education Center, Aichi University School of Medicine, Nagakute, Aichi 480-1195 Japan. Phone: +81 561 62 3311 ext. 1447. Fax: +81 561 63 1037. E-mail: shogo@aichi-med-u.ac.jp of cancer invasion because of the dominant upward longitudinal flow along the esophagus. 10, 11, 12, 13) Consequently, to assess the anatomical background of cancer prognosis, we conducted the present morphometrical study to analyze mucosal lymphatic vessels in the esophagus around 10 cm anal from squamous cell carcinoma occupying the upper or middle thoracic esophagus.
Materials and Methods
D2-40 immunohistochemistry for human lymphatic epithelium was performed on surgically removed specimens of the "mid or lower" thoracic esophagus from 27 patients with squamous cell carcinoma occupying the "u pper or mid" thoracic esophagus. The sites examined by D2-40 immunohistochemistry were located 10 cm anal to the pathologically examined cancer margin. This distance was easily estimated because, in the hospital that had treated the present patients, pathological sections had been routinely prepared along the "longitudinal axis" of the esophagus (Fig. 1A) . Conversely, for the present aim, cross-sectional histology was considered better because, in previous studies, 5, 6, 7, 10) the morphometry had been p erformed on cross-sections. Therefore, the longitudinal paraffin blocks were melted and the specimens were reembedded to allow transverse sections (6 μm thick) to be cut. After taking photos using a ×10 objective (at 3 or 4 sites along the entire circumferential wall of the esophagus at the 10 cm anal level; e.g., Fig. 1B ), we measured the entire length of mucosal lymphatic vessels within an objective field (1.2 mm along the muscularis mucosae). On the basis of 164 pathological reports (April 2003-September 2004) of curative surgeries of esophageal squamous cell carcinoma at Keiyu-kai Sapporo Hospital, we chose patients with upper or mid-thoracic squamous carcinoma from whom the esophagus had been surgically r emoved more than 10 cm anal to the cancer margin. We tried to eliminate any bias related to T-factor, N-factor and prognosis. The T and N factors were classified according to the criteria of the Japanese Society for Esophageal Diseases.
14) The population examined (Table 1) comprised 23 males and 4 females ranging in age from 79 to 51 years (70 -79 years, 14 patients; 60 -69, 10; 51-59, 3; other factors, see footnote of Table 2 ). None of the 27 patients had Barrett's esophagus.
For D2-40 immunohistochemistry, the primary antibody (monoclonal anti-human podoplanin; Nichirei D2-40 (code No. 413451), Tokyo, Japan; 1 : 100 dilution) was used after immersion in a ligand activator (Histofine SAB-PO Kit, code No. 415211, Nichirei, Tokyo, Japan) with autoclave treatment (105 °C, 10 min). The second antibody (Dako Chem Mate Envision Kit, Dako, Glostrup, Denmark) was labeled with horseradish peroxidase, and antigen-antibody reactions were detected using HRPcatalysis with diaminobenzidine. Counterstaining with hematoxylin was performed on the same samples.
Using cross-section histology with D2-40 immunohistochemistry, the fourth author (G.M.) took photos at hot spots of lymphatic vessel density (Weidner et al., 1991) in each of 3 sections at the 10-cm anal level (Fig. 1B) . After tracing of the D2-40-positive vessels (Fig. 1C) , the third author (M.N.) measured them using the ImageJ program (developed at the U.S. National Institutes of Health and available on the internet at http://rsb. info.nih.gov/ij/ ). The third author also calculated 1) the total number of mucosal lymphatic vessels in an objective field (1.2 mm along the muscularis mucosae) and 2) total circumferential length of vessels in an objective field. The second author (S.H.) evaluated the measured data using t-analysis, chi-squared analysis and one-way analysis of variance. The present study was conducted in accordance with the provisions of the Declaration of Helsinki, 1995 (as revised in Edinburgh in 2000). The protocol was approved by the ethics committees of the hospital of the first, fifth and sixth authors (H.N., M.F., M.H.) who performed the surgery or pathological examination.
results
In all 27 specimens examined, D2-40 successfully stained vessels in any layer of the esophagus. However, the measured lymphatic structures were limited to D2-40-positive vessels on the mucosal side of the muscularis mucosae (Fig. 1B) . There was a difference in the density and amount of vessels among 3 or 4 sections at a level almost 10 cm anal from the cancer margin. However, the difference was restricted to within 80% of the mean in the specimen. In this study, we averaged the data obtained from the 3-4 quadrants of the circumferential esophageal wall irrespective of the quadrants occupied by the cancer. We did not measure lymphatic vessels in and around the cancer because cross-sections were not obtained from this area.
The amount of mucosal lymphatic vessels (the total circumferential length of vessels in an objective field) ranged from 8.4 mm to 0.8 mm (mean, 1.22 mm), while the numerical density (the total number of mucosal lymphatic vessels in an objective field) ranged from 22.8 to 5.7 (mean, 6.50). Thus, the circumferential length of a hypothetical single vessel on average ranged from 1.48 to 0.06 mm (mean, 0.27 mm), although the vessel was likely to be continuous with another. The circumferential length of a single vessel (length/number in Table 1 ) depended on whether the vessel was dilated or collapsed. In 18 of the 27 patients, the length of mucosal vessels was estimated to be between 2.9 and 1.6 mm.
Correlations of the amount of mucosal lymphatic vessels with other factors are summarized in Table 2 . Despite a difference of more than 10-fold in the total circumferential length of mucosal vessels, none of the factors examined was significantly correlated with either the amount of Table 1 ), the numerical density (LV number) and single vessel size (length/number) ( Table 2) . Conversely, the distribution of each factor was so random (i.e., one of the lowest correlations) that the present sampling method appeared to have been ideal.
Discussion
Most of the previous data for esophageal mucosal lymphatic vessels have been obtained in and around areas of cancer using the hot spot method, 15) except for the study by Yajin et al. 10) in which various counting methods were employed. In cancer patients, the numerical density of vessels has ranged from 9.1 to 33.0 when corrected to v alues within a ×400 objective field. This objective field is much smaller (1/16th) than that used in the present study (×100).
1, 5, 6) However, the present numbers of lymphatic vessels were almost identical with the data obtained using a ×400 objective field. Thus, at a site 10 cm anal to a cancer, the numerical density may be much smaller than that in the cancer site although, to our regret, we have no data at and around the cancer. Actually, esophageal squamous cancer is often negative for VEGF-C mRNA. 16, 17, 18) The data by Yajin et al. 10) is located in and around the mean of the present numerical density. Thus, even at a distant site, the cancer seems to provide a great individual difference in the density.
Using specimens without cancer, Yajin et al. 10) measured the total circumferential length of mucosal vessels seen in a cross-section (not in an objective field). They also determined the "length of mucosal vessels per 1-mm length of the epithelium": 0.64 -1.11 mm (mean, 0.85 mm) at the mid-thoracic level, although they also reported v alues for other upper parts of the esophagus. Because of folding of the mucosa, the values obtained by Yajin et al. 10) is likely to be much greater than the length of mucosal vessels per 1-mm length of the "muscularis mucosa". Because of the present field along "1.2 mm" of the muscularis mucosae, to allow comparison with the data obtained by Yajin et al., 10) we need a 10/12 of the present data (e.g., 2.34 × 10/12 mm in males = 1.95 mm). Notably, it corresponds to more than 2-fold of Yajin et al. 10) In this context, the effect of mucosal folding is unlikely in the present data because the specimens were fully extended with pins when during fixation. Therefore, the present measured site, even at 10 cm anal from the cancer margin, seems to display a hypertrophic morphology under induction by the cancer. Conversely, the present morphology seems be different from the pre-existing or normal lymphatic morphology. Yajin et al. (2009) estimated the largest individual difference in the "length of mucosal vessels per 1-mm length of the epithelium" as 100% or 2-fold. In fact, the range for the total length of vessels in an objective field in 20 of the present 27 patients was 1.6 -3.2 mm (i.e., a 100% difference). Therefore, in these 20 patients, the present data seem to correspond to the "normal range" of individual variations. However, in the present study, the maximum and minimum amounts or lengths of the mucosal vessels were quite different: 8.4 vs. 0.8. Thus, despite the degree of agreement for 20 of the 27 patients (see above), the values for the other patients were likely to have been outside the normal range. More strictly, in the other 7 patients with the greatest amounts of vessels (Table 1) , the lymphatic morphology 10 cm anal from the cancer was likely to be strongly influenced by the cancer itself or related pathology such as pneumonia or other types of inflammation. In fact, most of these 7 patients died within 5 years after surgery, despite the fact that some of them had no lymph node involvement.
Consequently, a higher density or amount of preexisting mucosal lymphatic vessels may not always be correlated with larger numbers of nodal metastases. However, even at a site distant from a cancer, lymphatic vessel proliferation or dilation induced by cancer seems to occur irrespective of whether pre-existing vessels are rich or sparse. Numbers examined: males (n = 23), females (n = 4); dead patients (n = 15), alive patients (n = 12); submucosal or sm cancer (n = 7), non-sm cancer (n = 20); T-1 (n = 8), T-2 (n = 9), T-3 (n = 10); N-0 (n = 9), N-1 (n = 4), N-2 (n = 12), N-3 (n = 0), N-4 (n = 2).
